SIENNA BIOPHARM (NASDAQ:SNNA) CFO Richard D. Peterson bought 7,000 shares of the stock in a transaction on Tuesday, August 1st. The shares were acquired at an average cost of $15.00 per share, with a total value of $105,000.00. Following the acquisition, the chief financial officer now directly owns 7,000 shares in the company, valued at approximately $105,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
SIENNA BIOPHARM (NASDAQ:SNNA) opened at 19.76 on Friday. SIENNA BIOPHARM has a one year low of $18.50 and a one year high of $21.20.
SIENNA BIOPHARM Company Profile
Sienna Biopharmaceuticals, Inc is a United States-based medical dermatology and aesthetics company. The Company focuses on developing targeted therapies to treat inflammatory skin conditions and aesthetic concerns that impact the health and appearance of patients. Its research and clinical-stage candidates include programs, such as SNA-001, SNA-120 and SNA-125.
What are top analysts saying about SIENNA BIOPHARM? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SIENNA BIOPHARM and related companies.